No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - General
Tong Ren Tang Technologies Co. Ltd., a company founded in 1669 and based in Beijing, People's Republic of China, maintains extensive operations across Mainland China and Hong Kong. Its primary activities center on the manufacturing and sale of traditional Chinese medicine products. The company's involvement is comprehensive, extending to the cultivation, sourcing, and distribution of Chinese medicinal raw materials. Beyond its core offerings, Tong Ren Tang diversifies its product portfolio with items such as ointments, tea beverages, and specialized foot care solutions. The enterprise is also active in the technological advancement and commercialization of biological products, alongside Western pharmaceuticals, cosmetics, and general healthcare goods. Its distribution network includes both wholesale and retail channels for Chinese medicines and health-related products. Furthermore, Tong Ren Tang provides a broad spectrum of services, including medical research and development, Chinese medical consultation and treatment, advertising, internal and external surgical procedures, medical examinations, and hospital management. Additionally, the company engages in the processing of biochemical products, plant extraction, and the production of various food and daily chemical items.
www.tongrentangkj.comNo one on the platform currently holds 1666.HK.
No tracked institution reports a position in 1666.HK as of their last filing.
No one on the platform has traded 1666.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 11.9% | 15.8% | 17.9% | — | — | — |
| Rev. Growth % | -10.7% | 7.1% | ||||
| Profit Margin % | 6.1% | 8.2% | 10.0% | |||
| Free Cash Flow Margin % | 22.3% | 10.5% | 8.6% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $8.2B | +0.7% | $0.41 | $0.41–$0.41 | — | 1 |
| 2027 | $8.9B | +8.2% | $0.47 | $0.47–$0.47 | — | 1 |
| 2028 | $9.6B | +8.6% | $0.53 | $0.52–$0.53 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 1666.HKTong Ren Tang Technologies Co. Ltd. | $3.17 | +0.79% | $4.1B | — |
| 1501.HKShanghai Kindly Medical Instruments Co., Ltd. | $34.86 | -1.41% | $5.7B | — |
| 1763.HKChina Isotope & Radiation Corporation | $13.50 | +0.07% | $4.3B | — |
| 1789.HKAK Medical Holdings Limited | $4.88 | -0.61% | $5.2B | — |
| 1951.HKJinxin Fertility Group Limited |
| $2.09 |
| -1.18% |
| $5.6B |
| — |
| 2158.HKYidu Tech Inc. | $3.45 | -2.27% | $3.5B | — |
| 2273.HKGushengtang Holdings Limited | $27.08 | +0.07% | $5.7B | — |
Source: Financial Modeling Prep · peers by sector/industry